This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in ...

Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

The past year also saw IWS open a $30 million facility in North Arlington that is considered one of the most advanced ...

When the late Dr. David Ahlquist visited the streams of southern Minnesota with his Mayo Clinic colleagues, the trips would always transcend flyfishing and nature hikes. Driving back and forth to ...